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INTRODUCTION
Since the first reports of bone grafts, several materials have
appeared as an alternative for bone grafts. Therefore, specific
studies have been required to demonstrate the results obtained
with the use of nonautologous grafts in the spine.
Several combinations of bone inducers and different carriers
have been described in literature. In addition, the choice of an
experimental model can vary according to the study objectives.
Some methods of evaluation, such as manual palpation, plain
radiographs, computerized tomography, histological studies, and
biomechanical assays, are often used with useful results and
elucidate the alternatives for the use of BMPs in clinical practice.
MATERIAL AND METHODS
Twenty female   white rabbits weighing 2.0-2.5 kg, aged ap-
proximately one year, were isolated and confined. They were fed
ad libitum and received 100 g of pellets for rabbits and water.
They were clinically and neurologically evaluated daily.
Two groups of ten animals were formed, the first of them
was used as control. Animals from the control group were sub-
mitted to surgery under dissociative anesthesia, carried out
with  ketamine at the dose of 2.5 mg and xylazine at the dose
of 1 mg, diluted into 0.1 ml of distilled water for each 100 g of
animal’s body weight and given by deep intramuscular injec-
tion. A variable latency time was seen, ranging from 30 to 40
minutes. After pain reflex disappeared, epilation of the lum-
bar region was carried out (approximately 15 cm2) over the
L5-L6 segment.
Animals were then carried to the operating room and skin
was cleaned with the degerming agents povidone and chlorhe-
xidine. A posterior incision was made in the midline and spinous
processes and laminae were dissected so as to show L5 and L6
transverse processes. The latter were then decorticated and pre-
pared for grafting.
SUMMARY
The object of this study is to evaluate the use of the bone
densitometry as an evaluation method of the bone increment
observed when we used bovine BMP in intertransverse arthro-
desis of the rabbits’ lumbar spine. Since the discovery of the
BMP bone inductive properties, countless experimental models
have been proposed. This caused the need of setting up evalu-
ation methods to make possible a better understanding of the
found results. Twenty female rabbits from New Zealand, divided
in two groups, were submitted to the intertransverse arthrodesis
of the lumbar column, segment L5/L6, posterior side. In the first
group it was used autologous graft and in the second an associ-
ation of autologous graft with biocompound (bovine BMP, 1.0
mg and hydroxyapatite, 9.0 mg). The animals were maintained
in captivity, isolated and after 15 weeks submitted to the execu-
tion of bone densitometry by computerized tomography. 268
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bone density measures of the normal bone, 134 measures of
the newly formed bone by the association of the isolated autolo-
gous graft and 134 measures of the newly formed bone by the
association autologous graft and BMP were obtained, what de-
monstrated a significant bone increment after statistical analysis
(p=0.034) of the BMP/HAP group, when compared to the con-
trol group. We found this same variation of bone density analy-
zing the normal bone. The bone densitometry accomplished by
the computerized tomography is an alternative method to as-
sess the results when the BMP is used in experimental studies.
Further studies should be accomplished for better understan-
ding of the bone density variation found when the measures of
the normal bone in the two groups are compared.
Keywords: Bone morphogenetic protein (BMP); Bone transplan-
tation; Durapatite; Bone density; Tomography.
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Figure 1 - Sites where bone density
measurements were taken in the normal bone.
Figure 2 - Sites where bone density
measurements were taken in the graft area.
Homologous grafts were previously removed from the dona-
tor rabbit under general anesthesia. Animals were sacrificed, and
grafts were aseptically removed consisting of long bones (femo-
ra and tibiae). Grafts were then fragmented and transferred to
receptor sites (3 ml of graft for each side of the previously pre-
pared  transverse processes.
Nylon thread 3.0 was used to close the wound by planes,
musculature and skin.
Animals from the second group were submitted to the same
procedure described above. However, homologous grafts were
combined with a BMP-hydroxyapatite mixture. The composition
of the latter was the following: 0.25 cc of biocompound, consis-
ting of 9.0 mg of pure hydroxyapatite and 1.0 mg of BMP.
All procedures were submitted to the Ethics Committee of
the Federal University of São Paulo (UNIFESP - EPM)  for opini-
on and approval.
 Following procedures animals were isolated and confined.
They were fed and received water ad libitum for 15 weeks.
During follow-up, one animal from each study group develo-
ped progressive neurological deficit of lower limbs and presen-
ted total paraplegia in the fourth week of follow-up after surgery.
They also presented episodes of urinary tract infection. Both ani-
mals were excluded from the study. Other
complications were not seen.
Animals were then submitted to multis-
lice computerized tomography. The tomo-
graph used was the model SYNERGY, ma-
nufactured by GE MEDICAL SYSTEMS, and
had the following characteristics: 10cm
DFOV, 100kv, 150mA, 3mm gap, and  1mm
slice.
Each animal was anesthetized accor-
ding to the technique previously described
and submitted to tomography of lumbar
spine.
After the lateral section was obtained
(scalt), five tomographic sections were ob-
tained with a 3-mm gap between each other
so as to evaluate the L5-L6 segment.
For each of the tomographic sections,
three measurements of bone mineral den-
sity of normal vertebra and newly formed
bone were obtained according the radiolo-
gical technique of  Hounsfield(8) for both
groups (Figures 1 and 2).
The following results were obtained:
bone density values for normal bone of the
species used as experimental animal in 268,
bone density values of newly formed bone
from homologous graft alone in 134, and
bone density values of newly formed bone
from combined homologous graft and BMP/
HAP in 134.
RESULTS
Densitometric values were expressed in
Hounsfield units. They are shown in Tables
1 and 2.
Study results were statistically evaluated and are described
below.
STATISTICAL ANALYSIS
A variance analysis model with repeated measurements with
two factors (group and place) was used to compare results be-
tween the two groups. No difference was shown between the
study groups when responses in the treated area and in normal
bone were compared (p value for interaction factor = 0.859). In
addition, a statistically higher mean was found in the group 2, as
compared to the group 1 (p = 0.034), for normal bone and trea-
ted area measurements, the mean difference being 99 measu-
rement units between the two groups.
DISCUSSION
The present study used bone densitometry to evaluate the
use of BMP, at the dose of 1.0 mcg, combined with hydroxyapa-
tite as carriers in spine arthrodesis in rabbits.
According to Boden et al.(1) and Wozney(13), there were three
types of biocompounds with known bone-inducer activity: rhBMP-
tipo2, rhBMP tipo7, or rhOP1, and a mixture of purified proteins
extracted from bovine bone, chosen to
be evaluated in the present study due
to its easier availability and processing
in our country.
Hydroxyapatite, used as a carrier is
related to the category of ceramics, as
described by Seeherman et al.(12), is
able to act as a mechanical substrate
for new bone growth. In addition, it re-
mains in place for longer periods of
time.  According to reports by Helm et
al.(6), it has pores able to retain BMPs,
thus making its absoption difficult. The-
se combined characteristics lead
hydroxyapatite to have a great bone-
conductor potential. For this reason, this
was the product chosen to be used in
the present study.
Several animal models have been
described in literature. Sandhu and
Khan(11) have suggested the use of ra-
bbits as an experimental model for in-
tertransverse arthrodesis. In addition,
these models can be selected with uni-
formity and allow one to make evaluati-
ons that cannot be carried out in hu-
mans. However, Seeherman et al.(12)
emphasize that these models are not
predictive for humans. Boden(2) empha-
sizes that a judicious decortication of
posterior elements is required for ar-
throdesis, thus avoiding pseudarthrosis.
Another point to be taken into ac-
count, according Boden et al.(1), is the
choice of biocompound dosage to be
used; according to Damien et al.(5),
ACTA ORTOP BRAS 13(1) - 200544
Table 1 - Densitometric values in HU – Group I Table 2 - Densitometric values in HU – Group II
minimal doses of 0.15 mg of bovine BMP should be used for
experimental models in rabbits.
In the present study, a dose of 1.0 mg of BMP was chosen
because there is a threshold to be taken into account: proteins
do not show any activity below the threshold while the increment
in newly formed bone is directly proportional to the amount of
implanted BMP when doses exceeding the threshold are used
according to  Boden et al.(1).
Computerized tomography was used, according to the tech-
nique described by  Housfield(8), to assess bone densitometry
so as to evaluate the results obtained in the present study be-
cause this method is not widely used and there are no prece-
dents in literature establishing it as a technique of choice.
The most frequent ways to evaluate results suggested by
Seeherman et al.(12) include the radiological study in two positi-
ons, histological preparations, computerized tomography, and
biomechanical assays.
Some techniques are not routinely used, such as magnetic
nuclear resonance,   densitometry and even that carried out as
described by Magim and Delling(10) who utilized bone scintigra-
phy with technetium so as to show the bone-inducer activity of
type-7 BMP in pigs.
With the use of  bone densitometry in the evaluation of bovi-
ne BMP, at the dose of 1.0 mg, combined with hydroxyapatite as
a carrier in an experimental model in rabbits, a significant diffe-
rence was shown in the bone increment in the treated group, as
compared to the control group.
As for normal bone analysis, increased bone density was
shown in the BMP-treated group, as compared to the control group.
Densitometry was also used by Cochran et al.(4) who repor-
ted findings consistent with those found in the present study,
thus evidencing an increased bone mass in dogs used as an
experimental model. They used metallic implants of titanium and
BMP at the dose of 0.2 mg/ml. However, spine arthrodesis was
not carried out in the mentioned study; implants were inserted
into the mandible. Therefore, a direct comparison of results was
not possible.
In a study carried out by Hong et al.(7), densitometry was used
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in another experimental model to evaluate the use of type-2 BMP
in the repair of bone defects previously induced in the skull in
rabbits. Two different doses were used (0.5 and 1.0 mg of BMP).
No significant differences, however, were found between the
densitometric values obtained following the use of these doses.
Using a distinct experimental model in rabbits, Laffargue et
al.(9) reported no significant differences in any of the study groups,
as shown by in-vivo densitometry, when type-2 rh BMP at the
doses of 10 mcg and 40 mcg combined with beta-tricalcium
phosphate as a carrier was used to repair femoral bone defects.
Both the characteristics of the mentioned study and its results
differed from those of the present study.
The technique of densitometric evaluation described by
Hounsfield(8) was used in a clinical study by Burkus et al.(3) who
showed a significantly increased bone density in patients sub-
mitted to intersomatic arthrodesis where type-2 rhBMP, at doses
ranging from 4.2 to 8.4 mg, combined with titanium cage and a
collagen carrier  was used, as compared to those submitted to
autologous graft of iliac bone. They observed an increase of 213.9
Hounsfield units in the study group, as compared to an increase
of 64.3 Hounsfield units in the control group, 24 months follo-
wing surgery.
The use of densitometry to evaluate BMPs still causes some doubts.
Further studies will possibly elucidate some issues because
densitometry cannot be able to quantify bone mass under cer-
tain circumstances and despite the fact that bone mass is incre-
ased. This is occurs because several variables should be taken
into account, including the dose to be used, the animal species
to be studied, type of protein used in the study, segment time,
site of use of the biocompound, type of carrier, as well as stan-
dardization of densitometric measurements. These variables as
a whole lead to the fact that several studies are carried out diffe-
rently. Therefore, only few outcome parameters can be directly
compared.
Studies similar to the present one, carried out using the same
variables,  are not available in literature, making  the comparison
of results difficult.
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CONCLUSIONS
1. Bone densitometry through computerized axial tomogra-
phy allowed us to show that bone mass was increased in the
present study using an experimental model of rabbits submitted
to lumbar spine (L5-L6) arthrodesis  and implant of the biocom-
pound BMP-HAP combined with homologous graft, as compa-
red to autograft alone.
2. The increased bone mass shown in the study of normal
bone can be related to other mechanisms of action of BMPs.
Therefore, further studies are required to elucidate this
issue.
